1 Simple Reason to Buy NuScale Power (SMR) Right Now

NuScale Power shares are down over 80% from a $53.43 record high (Oct. 15, 2025) as deployments are delayed until the early 2030s. Analysts still project revenue rising from $31M in 2025 to $311M in 2028, with profitability remaining negative in the interim, and the stock trading at ~11x 2028 sales. The article frames the pullback as a long-term speculative entry ahead of potential “commercial reactor” growth in the 2030s, despite near-term execution risk.

Analysis

The market is likely making a category error: it is pricing SMR like a near-term operating company, while the equity behaves more like a long-dated project option with heavy dilution risk. That can create sharp rebounds, but only if milestones convert into bankable backlog; until then, every delay increases the probability that equity holders fund the gap while counterparties capture the economic rents.

The cleaner beneficiary is FLR, which monetizes design, procurement, and construction work before SMR ever reaches scale. If NuScale keeps slipping, FLR still gets paid for engineering hours and can recycle capital into higher-certainty infrastructure work, while SMR absorbs the binary execution and financing risk. Second-order, this also favors established nuclear-services and utility contractors over pure-play reactor developers: the market will increasingly pay for de-risking, not just technology narratives.

The contrarian view is that consensus is underweighting how punitive the time horizon is. A 2030s commercialization story may sound optional, but the gap between now and first revenue-bearing units is long enough for multiple reratings, financing rounds, and potentially obsolescence if competing SMR designs secure the first utility references. The key falsifier is not “growth someday”; it is whether SMR can convert engineering studies into durable, funded backlog with no major dilution over the next 12-18 months.

Risk is asymmetric in both directions: near-term squeeze risk exists if sentiment rotates back into nuclear hype, but structurally the stock likely needs evidence of financing visibility, not just headline deployments. If those milestones are missed, the next leg down could be driven by a lower probability of first-unit economics rather than by macro risk appetite.

Key Decisions for Investors

• Prefer FLR over SMR on a 6-12 month horizon: long FLR / short SMR as a quality-vs-optionality pair, targeting the spread to widen if SMR remains pre-revenue and dilution concerns resurface.
• If forced to express bullish SMR exposure, use small-size call spreads only after a confirmed contract-financing milestone; avoid outright stock size ahead of the next execution update because downside is still dominated by dilution and delay risk.
• Set an alert on SMR for any equity raise, convertible issuance, or guidance change over the next 1-3 quarters; that is the most likely catalyst to invalidate the long-term bull case and compress the multiple further.
• Watch FLR on pullbacks as the cleaner way to own nuclear buildout optionality: it has nearer-dated cash flow, less binary execution risk, and participates if SMR or other SMR projects move from concept to constructible projects.